Literature DB >> 24371660

Nodular lymphocyte predominant Hodgkin's lymphoma of the cervix: A case report of a rare entity.

Noha Jastaniyah1, Raymond Lai2, Robert Pearcey1.   

Abstract

► The clinical presentation of a case of NLPHL involving the uterine cervix. ► The immunohistochemical characteristics, the management and outcome of the described case. ► A brief review of the literature on current treatment strategies of early-stage NLPHL.

Entities:  

Keywords:  Nodular lymphocyte predominant Hodgkin's lymphoma; Uterine cervix

Year:  2012        PMID： 24371660      PMCID： PMC3862218          DOI： 10.1016/j.gynor.2012.11.001

Source DB:  PubMed          Journal:  Gynecol Oncol Case Rep        ISSN： 2211-338X


  11 in total

1.  Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001.

Authors:  Lindsay M Morton; Sophia S Wang; Susan S Devesa; Patricia Hartge; Dennis D Weisenburger; Martha S Linet
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

2.  Hodgkin's lymphoma relapse in the uterine cervix 15 years after the initial cure.

Authors:  Biljana S Mihaljevic; Maja D Perunicic Jovanovic; Ljubomir R Jakovic; Aleksandra M Sretenovic; Darinka V Boskovic
Journal:  Med Oncol       Date:  2007-10-12       Impact factor: 3.064

3.  Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group.

Authors:  Dennis A Eichenauer; Michael Fuchs; Annette Pluetschow; Beate Klimm; Teresa Halbsguth; Boris Böll; Bastian von Tresckow; Lucia Nogová; Peter Borchmann; Andreas Engert
Journal:  Blood       Date:  2011-08-09       Impact factor: 22.113

Review 4.  Primary lymphoma of the uterus and cervix: two case reports and review of the literature.

Authors:  Nazeerahamad Upanal; Anoop Enjeti
Journal:  Aust N Z J Obstet Gynaecol       Date:  2011-09-19       Impact factor: 2.100

5.  Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials.

Authors:  Alexander Shimabukuro-Vornhagen; Heinz Haverkamp; Andreas Engert; Leopold Balleisen; Peter Majunke; Günther Heil; Hans Theodor Eich; Harald Stein; Volker Diehl; Andreas Josting
Journal:  J Clin Oncol       Date:  2005-07-11       Impact factor: 44.544

6.  Lymphocyte-predominant and classical Hodgkin's lymphoma--comparison of outcomes.

Authors:  Lucia Nogová; Thorsten Reineke; Andreas Josting; Hans K Müller-Hermelink; Hans T Eich; Karolin Behringer; Rolf-Peter Müller; Volker Diehl; Andreas Engert
Journal:  Eur J Haematol Suppl       Date:  2005-07

7.  Long-term outcome after radiotherapy alone for lymphocyte-predominant Hodgkin lymphoma: a retrospective multicenter study of the Australasian Radiation Oncology Lymphoma Group.

Authors:  Andrew Wirth; Kally Yuen; Michael Barton; Daniel Roos; Kumar Gogna; Gary Pratt; Craig Macleod; Sean Bydder; Graeme Morgan; David Christie
Journal:  Cancer       Date:  2005-09-15       Impact factor: 6.860

8.  Treating limited-stage nodular lymphocyte predominant Hodgkin lymphoma similarly to classical Hodgkin lymphoma with ABVD may improve outcome.

Authors:  Kerry J Savage; Brian Skinnider; Mubarak Al-Mansour; Laurie H Sehn; Randy D Gascoyne; Joseph M Connors
Journal:  Blood       Date:  2011-08-26       Impact factor: 22.113

Review 9.  Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma.

Authors:  Lucia Nogová; Thomas Rudiger; Andreas Engert
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2006

10.  Early-stage, lymphocyte-predominant Hodgkin's lymphoma: patient outcomes from a large, single-institution series with long follow-up.

Authors:  Ronald C Chen; Michael S Chin; Andrea K Ng; Yang Feng; Donna Neuberg; Barbara Silver; Geraldine S Pinkus; Mary Ann Stevenson; Peter M Mauch
Journal:  J Clin Oncol       Date:  2009-11-23       Impact factor: 44.544
View more
  1 in total

1.  Primary nodular lymphocyte-predominant Hodgkin lymphoma of uterine cervix mimicking leiomyoma.

Authors:  Wan-Shan Li; Ren-Ching Wang; John Wang; Kung-Chao Chang
Journal:  Clin Case Rep       Date:  2015-03-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.